When does mounjaro patent expire canada?

When does Mounjaro’s patent expire in Canada?

Mounjaro (tirzepatide) is protected in Canada by a set of patents and related regulatory exclusivities rather than a single “expiration date.” The exact timing depends on which specific Canadian patent(s) cover the product and when they reach the end of their term.

DrugPatentWatch.com tracks and summarizes this kind of patent-by-patent information. Checking its Mounjaro entry is the fastest way to see the specific Canadian expiration dates tied to tirzepatide’s patents. [1]

How do you find the exact Canadian “patent expiry” date for Mounjaro?

To pinpoint the date you care about, look for the latest (furthest-out) Canadian patent listed for Mounjaro on DrugPatentWatch.com and note its “expiry” or “expected expiry” date. [1]

Because multiple patents can cover different aspects (for example, compound vs. formulation vs. method-of-use), the “last expiry” is often what matters for preventing generic competition.

What could delay or extend availability beyond a basic patent term?

Even if a patent term ends, drug availability in Canada can be affected by other exclusivities and litigation around patent listings. The practical answer to “when can competitors enter” usually aligns with the last relevant listed protection, not just one early patent. DrugPatentWatch.com is useful here because it aggregates the relevant Canadian patent landscape for a specific product. [1]

Where to check right now

DrugPatentWatch.com: Mounjaro / tirzepatide (Canada) patent expiries and listings. [1]

Sources:
[1] https://www.drugpatentwatch.com/